Articles

Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report

Miller, Christine; Taylor-Salmon, Emma; Emuren, Leonard; Landry, Marie; Gershon, Anne; Miller, George

Background
Herpes zoster (HZ) is the clinical syndrome associated with reactivation of latent varicella-zoster virus (VZV). Several factors have been implicated to promote VZV reactivation; these include immunosuppression, older age, mechanical trauma, physiologic stress, lymphopenia, and more recently, infection with severe acute respiratory syndrome coronavirus-2 (SARS- CoV-2). Recent reports suggest an increase in the number of HZ cases in the general population during the global COVID-19 pandemic. However, it is unknown what proportion of HZ during the pandemic is due to reactivation of wild-type or vaccine-strain VZV.

Case
Here we report the first known case of HZ concomitant with SARS-CoV2 infection in a 20-month-old female who was treated with a single dose of dexamethasone, due to reactivation of the vaccine-type strain of VZV after presenting with a worsening vesicular rash.

Conclusion
In this case, we were able to show vaccine-strain VZV reactivation in the context of a mild acute symptomatic COVID-19 infection in a toddler. Being able to recognize HZ quickly and effectively in a pediatric patient can help stave off the significant morbidity and mortality associated with disease process.

Files

  • thumnail for 12879_2023_Article_8809.pdf 12879_2023_Article_8809.pdf application/pdf 210 KB Download File

Also Published In

Title
BMC Infectious Diseases
DOI
https://doi.org/10.1186/s12879-023-08809-5

More About This Work

Published Here
December 4, 2024

Notes

COVID-19, Herpes Zoster (HZ), SARS-CoV-2, Shingles, Pediatric, Varicella Zoster Virus (VZV)